Atar Singh Kushwah
Biochemistry — Icahn School of Medicine at Mount Sinai, United States
Atar Singh Kushwah
LeadR Profile
Biochemistry
Subspecialties: Oncology - Hematology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr. Atar Singh Kushwah is an Assistant Professor at Manipal University Jaipur and an internationally trained molecular geneticist specializing in translational oncology. His research integrates DNA repair, cancer epigenetics, and host–microbiome interactions to develop precision biomarkers and therapeutic strategies for women's cancers.
I investigate how DNA repair, epigenetic regulation, and host–microbiome interactions shape cancer evolution and therapeutic response. My goal is to translate molecular discoveries into clinically relevant biomarkers and precision therapies that improve patient outcomes.
Organizations
Career arc: 2014 - 2026
Number : 31
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| An overview of CRISPR-artificial intelligence theranostics: Current and emerging applications. genes, intelligence, clustered regularly interspaced short palindromic repeats, point-of-care systems, rna, guide, kinetoplastida, biomarkers, nucleic acids, therapeutics, artificial intelligence, point-of-care testing | Biomater Transl | 2025 | 0 |
| Personalized Neoantigen Cancer Vaccines: Why Clinical Benefit Remains Inconsistent. vaccines, neoplasms, cancer vaccines | Crit Rev Oncol Hematol | 2026 | 0 |
| MicroRNAs and HPV oncogenes crosstalk, their biomarker potential and therapeutic utility in cervical cancer. oncogenes, uterine cervical neoplasms, micrornas, neoplasms, biomarkers, therapeutics, alphapapillomavirus, human papillomavirus viruses | Biomark Med | 2025 | 0 |
| Genetic and epigenetic landscape of O 6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics. methyltransferases, o(6)-methylguanine-dna methyltransferase, dna repair, promoter regions, genetic, neoplasms, multiple chronic conditions, biomarkers, therapeutics, dna | Explor Target Antitumor Ther | 2025 | 7 |
| Aurora kinases signaling in cancer: from molecular perception to targeted therapies. cells, aurora kinases, mitosis, neoplasms, perception, therapeutics | Mol Cancer Top journal | 2025 | 0 |
LeadR Networks
Main global connection map